Cancer Diagnostics Market Surges to USD 188.43 Billion by 2031, Propelled by 6.77% CAGR - Verified Market Research®

The cancer diagnostics market is driven by rising cancer prevalence, advancements in diagnostic technologies, and increased awareness and early screening programs. Government initiatives and funding for cancer research further propel market growth. However, high costs of diagnostic tests, limited accessibility in developing regions, and the risk of misdiagnosis restrain the market. Regulatory challenges and the complexity of cancer diagnostics also pose significant barriers to market expansion.

Lewes, Delaware, June 10, 2024 (GLOBE NEWSWIRE) -- The Global Cancer Diagnostics Market is projected to grow at a CAGR of 6.77% from 2024 to 2031, according to a new report published by Verified Market Research®. The report reveals that the market was valued at USD 111.70 Billion in 2024 and is expected to reach USD 188.43 Billion by the end of the forecast period.

Download PDF Brochure:

Browse in-depth TOC onGlobal Cancer Diagnostics Market

202 - Pages

126 – Tables

37 – Figures

Scope Of The Report

UNITValue (USD Billion)
KEY COMPANIES PROFILEDIllumina, Inc., Koninklijke Philips N.V., Agilent Technologies, Inc., General Electric Company, F. Hoffmann-La Roche Ltd, Becton, Dickinson, and Company.
  • By Diagnostic Type
  • By Cancer Type
  • By Geography
CUSTOMIZATION SCOPEFree report customization (equivalent up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope

Cancer Diagnostics Market Overview

Rising Cancer Prevalence: The rising prevalence of cancer worldwide is a major factor contributing to the growth of the Cancer Diagnostics Market. The increasing prevalence of cancer necessitates a greater need for prompt and precise diagnostic treatments. This increase in demand motivates healthcare providers to allocate resources towards acquiring sophisticated diagnostic equipment, which in turn leads to the growth of market prospects and the promotion of innovation within the industry.

Technological Advancements: Advancements in diagnostic instruments have a substantial influence on the Cancer Diagnostics Market. Technological advancements such as liquid biopsy, next-generation sequencing, and AI-enhanced imaging boost the precision and efficiency of detecting diseases. These technological developments entice investments and collaborations, driving industry expansion and providing competitive benefits.

Government Initiatives and Funding: Government assistance in the form of financial support and strategic initiatives is essential for the development and success of the Cancer Diagnostics Market. Market accessibility is enhanced by policies that promote cancer research, early detection programs, and subsidies for diagnostic equipment. This funding stimulates research and development, propelling the market forward and guaranteeing widespread expansion.

To Purchase a Comprehensive Report Analysis:

High Costs of Diagnostic Tests: The exorbitant expense associated with sophisticated cancer diagnostic tests poses a substantial obstacle to the growth of the Cancer Diagnostics Market. These expenditures can restrict accessibility, particularly in low- and middle-income nations, impeding market entry. As a result, the market is encountering difficulties in attaining widespread acceptance of advanced diagnostic tools.

Limited Accessibility in Developing Regions: The Cancer Diagnostics Market is restricted by the lack of adequate infrastructure and healthcare resources in underdeveloped countries. Limited availability of state-of-the-art diagnostic technology hinders the prompt and precise identification of cancer, impeding the expansion of the market. It is essential to tackle these inequalities in order to successfully expand into the global market.

Risk of Misdiagnosis: The potential for incorrect diagnosis presents a significant obstacle to the Cancer Diagnostics Market. Erroneous outcomes can result in unsuitable therapeutic strategies, patient anguish, and escalated medical expenses. Ensuring the dependability and precision of diagnostic tests is crucial for upholding market credibility and cultivating confidence among healthcare professionals.

Geographic Dominance:

North America's prominent position in the Cancer Diagnostics Market is attributed to its advanced healthcare infrastructure, high prevalence of cancer, and substantial investments in research and development. The region's market leadership is strengthened by the presence of prominent market players and government efforts that provide support. Europe constantly monitors the situation because of its strong healthcare systems and increasing awareness of cancer. Asia-Pacific is seeing tremendous growth due to rising healthcare spending, expanding patient populations, and breakthroughs in technology.

Cancer Diagnostics Market Key Players Shaping the Future

Major players, including Illumina, Inc., Koninklijke Philips N.V., Agilent Technologies, Inc., General Electric Company, F. Hoffmann-La Roche Ltd, Becton, Dickinson, and Company. and more, play a pivotal role in shaping the future of the Cancer Diagnostics Market. Financial statements, product benchmarking, and SWOT analysis provide valuable insights into the industry's key players.

Cancer Diagnostics Market Segment Analysis

Based on the research, Verified Market Research® has segmented the global Cancer Diagnostics Market into Diagnostic Type, Cancer Type, And Geography.

To get market data, market insights, and a comprehensive analysis of the Global Cancer Diagnostics Market, please Contact Verified Market Research®.

  • Cancer Diagnostics Market, by Diagnostic Type
    • Biopsy and Cytology Tests
    • Diagnostic Imaging Tests
    • Endoscopy
    • Genetic Tests
    • Others
  • Cancer Diagnostics Market, by Cancer Type
    • Breast Cancer
    • Leukemia
    • Pancreatic Cancer
    • Prostate Cancer
    • Colon and Rectal Cancer
    • Others
  • Cancer Diagnostics Market, by Geography
    • North America
      • U.S
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • U.K
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Rest of Asia Pacific
    • ROW
      • Middle East & Africa
      • Latin America

Browse Related Reports:

Global Bladder Cancer Market Size By Type (Diagnosis (transitional cell carcinoma), Treatment), Cancer Type (Transitional Bladder Cancer, Invasive Bladder Cancer, Superficial Bladder Cancer), By Geography, And Forecast

Global Liver Cancer Treatment Market Size By Process (Targeted Therapy, Chemotherapy), By Type (Hepatocellular Carcinoma, Cholangio Carcinoma), By End-User (Hospitals, Clinics), By Geography, And Forecast

Global Peptide Cancer Vaccine Market Size By Type (Personalized Peptide Vaccine, Peptide-Pulsed Dendritic Cancer Vaccine), By Technology (Recombinant Cancer Vaccines, Whole-cell Cancer Vaccines), By Application (Breast Cancer, Lung Cancer), By Geography, And Forecast

Global Nephroblastoma Treatment Market Size By Type (Favourable Histology, Unfavorable Histology), By Application (Hospitals, Cancer Centers, Surgical Centers), By Geography, And Forecast

Top 9 Cancer Immunotherapy Companies supporting infirmaries to fight against cancer

Visualize Cancer Diagnostics Market using Verified Market Intelligence -:

Verified Market Intelligence is our BI Enabled Platform for narrative storytelling in this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue-impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us

Verified Market Research® stands at the forefront as a global leader in Research and Consulting, offering unparalleled analytical research solutions that empower organizations with the insights needed for critical business decisions. Celebrating 10+ years of service, VMR has been instrumental in providing founders and companies with precise, up-to-date research data.

With a team of 500+ Analysts and subject matter experts, VMR leverages internationally recognized research methodologies for data collection and analyses, covering over 15,000 high impact and niche markets. This robust team ensures data integrity and offers insights that are both informative and actionable, tailored to the strategic needs of businesses across various industries.

VMR's domain expertise is recognized across 14 key industries, including Semiconductor & Electronics, Healthcare & Pharmaceuticals, Energy, Technology, Automobiles, Defense, Mining, Manufacturing, Retail, and Agriculture & Food. In-depth market analysis cover over 52 countries, with advanced data collection methods and sophisticated research techniques being utilized. This approach allows for actionable insights to be furnished by seasoned analysts, equipping clients with the essential knowledge necessary for critical revenue decisions across these varied and vital industries.

Verified Market Research® is also a member of ESOMAR, an organization renowned for setting the benchmark in ethical and professional standards in market research. This affiliation highlights VMR's dedication to conducting research with integrity and reliability, ensuring that the insights offered are not only valuable but also ethically sourced and respected worldwide.


Contact Data